With biosimilars entering the market for the treatment of osteoporosis, there is a lot healthcare providers need to know. On this episode, Dr. Alan Low, a Clinical Professor in the Faculty of Pharmaceutical Sciences at the University of British Columbia, Care Director at MedInfuse Health, Primary Care Pharmacist / Pharmacy Lead at BioPro Biologics Pharmacy Clinical and a member of Osteoporosis Canada’s Scientific Advisory Council, discusses how biologics and biosimilars work, the benefits of biosimilars and how to speak to patients about these new treatment options.

Ver todos los episodios